Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | CASP7 | P55210 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3747895 | 0.84 | FTO (0.35) | — | |
| SCHEMBL215137 | 0.82 | LMNA (0.35) | GSTP1LMNAMAPTKDM4EGLA | |
| SCHEMBL4575132 | 0.80 | FTO (0.34) | LMNAMAPTKDM4EGLAGAA | |
| SCHEMBL4236674 | 0.72 | LMNA (0.32) | GSTP1LMNAMAPTKDM4EGLA | |
| SCHEMBL2784206 | 0.70 | FTO (0.34) | — | |
| SCHEMBL15349331 | 0.69 | GSTP1 (0.48) | GSTP1LMNAMAPTKDM4EGLA | |
| SCHEMBL29349570 | 0.68 | MAPT (0.66) | GSTP1LMNAMAPTGAAMEN1 | |
| SCHEMBL1024927 | 0.68 | MAPT (0.66) | GSTP1LMNAMAPTGAAMEN1 | |
| SCHEMBL29382186 | 0.66 | ALDH1A1 (0.52) | GSTP1LMNAMAPTKDM4EGAA | |
| SCHEMBL20419954 | 0.66 | ALDH1A1 (0.49) | GSTP1LMNAMAPTKDM4EGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1993593-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING SODS AND GLIADIN BASED PEPTIDE FRAGMENTS | ISOCELL S A (FR) | 2015-08-26 | — | — | EP | disclosed |
| US-8092794-B2 | Pharmaceutical compositions comprising SODs and prolamine based peptide fragments | ISOCELL PHARMA S.A. (FR) | 2012-01-10 | — | — | US | disclosed |
| US-20090226409-A1 | Pharmaceutical Compositions Comprising Sods and Prolamine Based Peptide Fragments | ISOCELL PHARMA S.A. (FR) | 2009-09-10 | — | — | US | disclosed |
| EP-1993593-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING SODS AND PROLAMINE BASED PEPTIDE FRAGMENTS | Isocell Pharma S.A. (FR) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007105024-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING SODS AND PROLAMINE BASED PEPTIDE FRAGMENTS | ISOCELL PHARMA S.A. (FR) | 2007-09-20 | — | — | WO | disclosed |